FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386530823> ?p ?o ?g. }

• W4386530823 endingPage "1297" @default.
• W4386530823 startingPage "1287" @default.
• W4386530823 abstract "Abstract Introduction Promptly providing new drugs to fulfill unmet medical needs requires changes in drug development and registration processes. Health Authorities (HAs) considered as reference due to their experience and acknowledgement (Food and Drug Administration [FDA] among others) already consider innovative clinical trial (CT) designs and flexible approval procedures, but Latin America (LATAM) regulations are still far. A comparison was performed to identify gaps. Materials and Methods CT requirements for drug Marketing Authorization Application (MAA) and CT approval regulations were compared between LATAM and reference HAs (FDA/European Medicines Agency [EMA]/Health-Canada/Swissmedic/Therapeutic Goods Administration [TGA]/Pharmaceuticals and Medical Devices Agency [PMDA]), as of August 2022. Procedure included reference HAs regulations review, item selection, identification in LATAM regulations, and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines (ICH-E6[R2]/ICH-E8[R1]) implementation revision. Results For MAA, specific application requirements or ICH guideline M4(R4) on common technical document (CTD) adoption are generally stated, and phase-I/III performance is mandatory (explicitly/implicitly). Faster patient access procedures are infrequent: Priority-drug programs, conditional authorizations, or expedited procedures are scarce or non-existent. Regulatory reliance procedures are adopted through different pathways. Regarding CT approval, innovative/complex CT designs are not prohibited but usually omitted. Some countries implemented adapted CT conducting during the COVID-19 pandemic. Early scientific advice meetings (HA-sponsor) are occasionally considered. Most countries are not formally ICH-joined. Conclusions LATAM regulations must adapt to new regulatory standards (FDA/EMA/ICH) through implementation of frequent updates, reliance/expedited procedures, early HA-sponsor interactions, innovative/complex CTs, mandatory phase-III reaching elimination, and decentralized elements for CT conducting." @default.
• W4386530823 created "2023-09-09" @default.
• W4386530823 creator A5004021159 @default.
• W4386530823 creator A5006523480 @default.
• W4386530823 creator A5019998176 @default.
• W4386530823 creator A5058800911 @default.
• W4386530823 creator A5068931629 @default.
• W4386530823 creator A5092772790 @default.
• W4386530823 creator A5092772791 @default.
• W4386530823 date "2023-09-08" @default.
• W4386530823 modified "2023-10-18" @default.
• W4386530823 title "Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications" @default.
• W4386530823 cites W2512907691 @default.
• W4386530823 cites W2773935049 @default.
• W4386530823 cites W2805313504 @default.
• W4386530823 cites W2888632634 @default.
• W4386530823 cites W2999793242 @default.
• W4386530823 cites W3005434414 @default.
• W4386530823 cites W3018220265 @default.
• W4386530823 cites W3034153068 @default.
• W4386530823 cites W3081676239 @default.
• W4386530823 cites W3099510265 @default.
• W4386530823 cites W3124236149 @default.
• W4386530823 cites W3127291294 @default.
• W4386530823 cites W3131040294 @default.
• W4386530823 cites W3134530867 @default.
• W4386530823 cites W3136465602 @default.
• W4386530823 cites W3155755939 @default.
• W4386530823 cites W3213674978 @default.
• W4386530823 cites W4210567612 @default.
• W4386530823 cites W4213237753 @default.
• W4386530823 cites W4220978357 @default.
• W4386530823 cites W4224750762 @default.
• W4386530823 cites W4283271081 @default.
• W4386530823 cites W4293767654 @default.
• W4386530823 cites W4294125057 @default.
• W4386530823 doi "https://doi.org/10.1007/s43441-023-00565-7" @default.
• W4386530823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37682461" @default.
• W4386530823 hasPublicationYear "2023" @default.
• W4386530823 type Work @default.
• W4386530823 citedByCount "0" @default.
• W4386530823 crossrefType "journal-article" @default.
• W4386530823 hasAuthorship W4386530823A5004021159 @default.
• W4386530823 hasAuthorship W4386530823A5006523480 @default.
• W4386530823 hasAuthorship W4386530823A5019998176 @default.
• W4386530823 hasAuthorship W4386530823A5058800911 @default.
• W4386530823 hasAuthorship W4386530823A5068931629 @default.
• W4386530823 hasAuthorship W4386530823A5092772790 @default.
• W4386530823 hasAuthorship W4386530823A5092772791 @default.
• W4386530823 hasBestOaLocation W43865308231 @default.
• W4386530823 hasConcept C104863432 @default.
• W4386530823 hasConcept C108170787 @default.
• W4386530823 hasConcept C108759981 @default.
• W4386530823 hasConcept C111472728 @default.
• W4386530823 hasConcept C121332964 @default.
• W4386530823 hasConcept C138885662 @default.
• W4386530823 hasConcept C142724271 @default.
• W4386530823 hasConcept C144133560 @default.
• W4386530823 hasConcept C17744445 @default.
• W4386530823 hasConcept C24890656 @default.
• W4386530823 hasConcept C2777589142 @default.
• W4386530823 hasConcept C2778917124 @default.
• W4386530823 hasConcept C2779962950 @default.
• W4386530823 hasConcept C2780182762 @default.
• W4386530823 hasConcept C3018890749 @default.
• W4386530823 hasConcept C3019398576 @default.
• W4386530823 hasConcept C3116431 @default.
• W4386530823 hasConcept C38652104 @default.
• W4386530823 hasConcept C41008148 @default.
• W4386530823 hasConcept C512399662 @default.
• W4386530823 hasConcept C545542383 @default.
• W4386530823 hasConcept C60644358 @default.
• W4386530823 hasConcept C71924100 @default.
• W4386530823 hasConcept C86803240 @default.
• W4386530823 hasConceptScore W4386530823C104863432 @default.
• W4386530823 hasConceptScore W4386530823C108170787 @default.
• W4386530823 hasConceptScore W4386530823C108759981 @default.
• W4386530823 hasConceptScore W4386530823C111472728 @default.
• W4386530823 hasConceptScore W4386530823C121332964 @default.
• W4386530823 hasConceptScore W4386530823C138885662 @default.
• W4386530823 hasConceptScore W4386530823C142724271 @default.
• W4386530823 hasConceptScore W4386530823C144133560 @default.
• W4386530823 hasConceptScore W4386530823C17744445 @default.
• W4386530823 hasConceptScore W4386530823C24890656 @default.
• W4386530823 hasConceptScore W4386530823C2777589142 @default.
• W4386530823 hasConceptScore W4386530823C2778917124 @default.
• W4386530823 hasConceptScore W4386530823C2779962950 @default.
• W4386530823 hasConceptScore W4386530823C2780182762 @default.
• W4386530823 hasConceptScore W4386530823C3018890749 @default.
• W4386530823 hasConceptScore W4386530823C3019398576 @default.
• W4386530823 hasConceptScore W4386530823C3116431 @default.
• W4386530823 hasConceptScore W4386530823C38652104 @default.
• W4386530823 hasConceptScore W4386530823C41008148 @default.
• W4386530823 hasConceptScore W4386530823C512399662 @default.
• W4386530823 hasConceptScore W4386530823C545542383 @default.
• W4386530823 hasConceptScore W4386530823C60644358 @default.
• W4386530823 hasConceptScore W4386530823C71924100 @default.
• W4386530823 hasConceptScore W4386530823C86803240 @default.

• next